Microba Life Sciences Limited (ASX:MAP) Insider Pasquale (Paddy) Rombola Acquires 200,000 Shares of Stock

Microba Life Sciences Limited (ASX:MAP) insider Pasquale (Paddy) Rombola purchased 200,000 shares of the business’s stock in a transaction on Tuesday, November 19th. The stock was acquired at an average price of A$0.17 ($0.11) per share, with a total value of A$34,200.00 ($22,207.79).

Microba Life Sciences Stock Performance

The company has a debt-to-equity ratio of 3.84, a current ratio of 2.61 and a quick ratio of 6.50.

About Microba Life Sciences

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development.